Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320070358> ?p ?o ?g. }
- W4320070358 endingPage "29" @default.
- W4320070358 startingPage "20" @default.
- W4320070358 abstract "IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS) are rare primary glomerulopathies, though the incidence of IgAN is greater. Endothelin 1 (ET-1) and angiotensin II (Ang II) are implicated in the development and progression of IgAN and FSGS. Both conditions impact health-related quality of life (HRQoL) and may lead to kidney failure. IgAN and FSGS are both evidenced clinically by proteinuria, with a greater degree of such associated with more progressive disease and shorter times to kidney failure. Accordingly, the reduction of proteinuria in patients with these conditions is a key target. Currently, IgAN and FSGS treatments are unsuccessful or only partially successful in a number of patients. Immunosuppressant therapy is first-line for primary FSGS and utilised for patients with IgAN who remain at high risk of progression despite maximal supportive care; however, while effective, there is a significant risk of toxicity and relapse is frequent. A number of clinical trials are ongoing to investigate the use of non-immunosuppressive agents in the management of these conditions. The dual endothelin Type A receptor/Ang II subtype 1 receptor (ETAR/AT1R) antagonist (DEARA) sparsentan is currently being assessed as a means to control kidney disease progression. Interim study results show that sparsentan can lead to greater reductions in proteinuria than AT1R antagonism alone in IgAN and more patients reaching partial remission (PR) in FSGS. Herein, a symposium by leading experts at the European Renal Association (ERA) 59th Congress in Paris, 19th−22nd May 2022, is presented. It highlights IgAN and FSGS and the role of proteinuria in these conditions, and how targeting ET-1 and Ang II can lead to a reduction in proteinuria in IgAN and potential FSGS PR." @default.
- W4320070358 created "2023-02-12" @default.
- W4320070358 creator A5027590697 @default.
- W4320070358 date "2022-06-30" @default.
- W4320070358 modified "2023-09-26" @default.
- W4320070358 title "The Dual Role of Endothelin-1 and Angiotensin II in Disease Progression of Focal Segmental Glomerulosclerosis and IgA Nephropathy" @default.
- W4320070358 cites W1564596764 @default.
- W4320070358 cites W1891665744 @default.
- W4320070358 cites W1991210746 @default.
- W4320070358 cites W2015170224 @default.
- W4320070358 cites W2019807737 @default.
- W4320070358 cites W2040176336 @default.
- W4320070358 cites W2046529630 @default.
- W4320070358 cites W2059769088 @default.
- W4320070358 cites W2068622105 @default.
- W4320070358 cites W2069377309 @default.
- W4320070358 cites W2080073410 @default.
- W4320070358 cites W2096977413 @default.
- W4320070358 cites W2099963452 @default.
- W4320070358 cites W2102180002 @default.
- W4320070358 cites W2108829447 @default.
- W4320070358 cites W2115531910 @default.
- W4320070358 cites W2117004007 @default.
- W4320070358 cites W2122770875 @default.
- W4320070358 cites W2123917517 @default.
- W4320070358 cites W2136212618 @default.
- W4320070358 cites W2142522073 @default.
- W4320070358 cites W2148643197 @default.
- W4320070358 cites W2151438241 @default.
- W4320070358 cites W2162337442 @default.
- W4320070358 cites W2290646159 @default.
- W4320070358 cites W2309649143 @default.
- W4320070358 cites W2327067198 @default.
- W4320070358 cites W2708432113 @default.
- W4320070358 cites W2727604819 @default.
- W4320070358 cites W2765660894 @default.
- W4320070358 cites W2783430372 @default.
- W4320070358 cites W2788969813 @default.
- W4320070358 cites W2789243917 @default.
- W4320070358 cites W2911011964 @default.
- W4320070358 cites W2939528548 @default.
- W4320070358 cites W2943688236 @default.
- W4320070358 cites W2999129752 @default.
- W4320070358 cites W3027793481 @default.
- W4320070358 cites W3040274572 @default.
- W4320070358 cites W3109865727 @default.
- W4320070358 cites W3125260920 @default.
- W4320070358 cites W3128308244 @default.
- W4320070358 cites W3137431242 @default.
- W4320070358 cites W3152584659 @default.
- W4320070358 cites W3153201970 @default.
- W4320070358 cites W3157591377 @default.
- W4320070358 cites W3171856449 @default.
- W4320070358 cites W3174757634 @default.
- W4320070358 cites W3199077271 @default.
- W4320070358 cites W4211190065 @default.
- W4320070358 cites W4229029524 @default.
- W4320070358 cites W4229508150 @default.
- W4320070358 cites W4234582290 @default.
- W4320070358 cites W4238287193 @default.
- W4320070358 cites W4244702719 @default.
- W4320070358 cites W4244982882 @default.
- W4320070358 cites W4248527279 @default.
- W4320070358 cites W4296794353 @default.
- W4320070358 doi "https://doi.org/10.33590/emjnephrol/22c0912" @default.
- W4320070358 hasPublicationYear "2022" @default.
- W4320070358 type Work @default.
- W4320070358 citedByCount "1" @default.
- W4320070358 countsByYear W43200703582023 @default.
- W4320070358 crossrefType "journal-article" @default.
- W4320070358 hasAuthorship W4320070358A5027590697 @default.
- W4320070358 hasBestOaLocation W43200703581 @default.
- W4320070358 hasConcept C126322002 @default.
- W4320070358 hasConcept C126894567 @default.
- W4320070358 hasConcept C134018914 @default.
- W4320070358 hasConcept C2777390665 @default.
- W4320070358 hasConcept C2778415529 @default.
- W4320070358 hasConcept C2778653478 @default.
- W4320070358 hasConcept C2779561371 @default.
- W4320070358 hasConcept C2780091579 @default.
- W4320070358 hasConcept C2781184683 @default.
- W4320070358 hasConcept C555293320 @default.
- W4320070358 hasConcept C71924100 @default.
- W4320070358 hasConcept C90924648 @default.
- W4320070358 hasConceptScore W4320070358C126322002 @default.
- W4320070358 hasConceptScore W4320070358C126894567 @default.
- W4320070358 hasConceptScore W4320070358C134018914 @default.
- W4320070358 hasConceptScore W4320070358C2777390665 @default.
- W4320070358 hasConceptScore W4320070358C2778415529 @default.
- W4320070358 hasConceptScore W4320070358C2778653478 @default.
- W4320070358 hasConceptScore W4320070358C2779561371 @default.
- W4320070358 hasConceptScore W4320070358C2780091579 @default.
- W4320070358 hasConceptScore W4320070358C2781184683 @default.
- W4320070358 hasConceptScore W4320070358C555293320 @default.
- W4320070358 hasConceptScore W4320070358C71924100 @default.
- W4320070358 hasConceptScore W4320070358C90924648 @default.
- W4320070358 hasLocation W43200703581 @default.
- W4320070358 hasOpenAccess W4320070358 @default.